NRC Health: 10-Q filed 2020-11-06
What NRC Health reported in its quarterly report filed 2020-11-06 (fiscal Q3 2020): 47 published measures, 134 facts as tagged in accession 0001437749-20-022940.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-11-06
- Fiscal period
- fiscal Q3 2020
- Accession
- 0001437749-20-022940 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NRC Health filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 127,246,000 | USD | |
| At 2019-12-31 | 110,685,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 70,517,000 | USD | |
| At 2019-12-31 | 77,793,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 56,729,000 | USD | |
| At 2020-06-30 | 45,574,000 | USD | |
| At 2020-03-31 | 37,297,000 | USD | |
| At 2019-12-31 | 32,892,000 | USD | |
| At 2019-09-30 | 28,975,000 | USD | |
| At 2019-06-30 | 25,967,000 | USD | |
| At 2019-03-31 | 22,739,000 | USD | |
| At 2018-12-31 | 19,083,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 21,855,000 | USD | |
| At 2019-12-31 | 13,517,000 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 24,419,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 28,974,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 2,435,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 3,429,000 | USD | 273 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 33,477,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 98,503,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 32,465,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 95,359,000 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -13,582,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -30,575,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -2,175,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -3,429,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | -69,587,000 | USD | |
| At 2019-12-31 | -93,357,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 25,219,000 | shares | 92 |
| 2020-01-01 to 2020-09-30 | 25,113,000 | shares | 274 |
| 2019-07-01 to 2019-09-30 | 24,827,000 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 24,794,000 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 25,704,000 | shares | 92 |
| 2020-01-01 to 2020-09-30 | 25,701,000 | shares | 274 |
| 2019-07-01 to 2019-09-30 | 25,741,000 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 25,624,000 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 0.38 | USD/shares | 92 |
| 2020-01-01 to 2020-09-30 | 1.15 | USD/shares | 274 |
| 2019-07-01 to 2019-09-30 | 0.33 | USD/shares | 92 |
| 2019-01-01 to 2019-09-30 | 0.95 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 0.37 | USD/shares | 92 |
| 2020-01-01 to 2020-09-30 | 1.13 | USD/shares | 274 |
| 2019-07-01 to 2019-09-30 | 0.31 | USD/shares | 92 |
| 2019-01-01 to 2019-09-30 | 0.92 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 2,088,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 2,545,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 1,690,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 5,446,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 12,267,000 | USD | |
| At 2019-12-31 | 13,530,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 747,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 917,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 12,021,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 32,490,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 10,220,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 31,073,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 47,366,000 | USD | |
| At 2019-12-31 | 29,157,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 451,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 1,366,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 510,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,613,000 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 32,073,000 | USD | |
| At 2019-12-31 | 38,155,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 725,000 | USD | |
| At 2019-12-31 | 1,279,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 57,875,000 | USD | |
| At 2019-12-31 | 57,935,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 17,426,000 | USD | |
| At 2019-12-31 | 11,639,000 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 7,953,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 25,554,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 8,706,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 24,732,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 25,321,141 | shares | |
| At 2019-12-31 | 24,947,500 | shares |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,213,000 | USD | |
| At 2019-12-31 | 1,628,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 31,706,000 | USD | |
| At 2019-12-31 | 34,281,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 45,143,000 | USD | |
| At 2019-12-31 | 42,078,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 32,876,000 | USD | |
| At 2019-12-31 | 28,548,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,462,000 | USD | |
| At 2019-12-31 | 1,728,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 2,521,000 | USD | |
| At 2019-12-31 | 2,503,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 3,596,000 | USD | |
| At 2019-12-31 | 2,444,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 2,616,000 | USD | |
| At 2019-12-31 | 3,408,000 | USD |
Current contract liabilities
Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 17,328,000 | USD | |
| At 2019-12-31 | 16,354,000 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 7,265,000 | USD | |
| At 2019-12-31 | 7,399,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 11,666,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 31,593,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 9,809,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 29,154,000 | USD | 273 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 9,578,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 29,048,000 | USD | 274 |
| 2020-04-01 to 2020-06-30 | 7,715,000 | USD | 91 |
| 2020-01-01 to 2020-03-31 | 11,755,000 | USD | 91 |
| 2019-07-01 to 2019-09-30 | 8,119,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 23,708,000 | USD | 273 |
| 2019-04-01 to 2019-06-30 | 7,393,000 | USD | 91 |
| 2019-01-01 to 2019-03-31 | 8,196,000 | USD | 90 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 9,827,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 28,634,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 7,973,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 24,182,000 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 9,561,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 28,993,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 8,092,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 23,628,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 94,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 454,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 89,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -330,000 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -355,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -897,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | -411,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -1,919,000 | USD | 273 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -134,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 919,000 | USD | 273 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 1,315,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 1,558,000 | USD | 273 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 5,034,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 5,607,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 5,830,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 3,343,000 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -681,000 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 69,000 | USD | 273 |
Inspect the source
- Entity
- NRC Health / CIK 0000070487
- Captured
- 2026-09-19T14:50:09.097Z
- SEC response SHA-256
6434e4543029978a17e4d65a6e98b3ad20e506fbb93c8df07c51346145d9f6d6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000070487.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))